Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Anticipation Builds for Nuveis Quarterly Earnings Report

Elaine Mendonca by Elaine Mendonca
March 4, 2024
in Breaking News
0
Finances
0
SHARES
11
VIEWS
Share on FacebookShare on Twitter

Nuvei (NASDAQ:NVEI) is set to unveil its latest quarterly earnings report on March 5, 2024. Analysts are forecasting an earnings per share (EPS) of $0.45 for Nuvei. Investors are eagerly awaiting to see if Nuvei will exceed this prediction and offer positive guidance for future growth, as guidance tends to have a greater impact on stock prices than earnings beats or misses.

In the previous quarter, Nuvei missed EPS expectations by $0.01, but the stock price soared by 19.75% the next day. Nuvei’s historical performance shows that there have been fluctuations in EPS estimates and actual results, impacting stock price movements. For example, in Q3 2023, Nuvei’s EPS estimate was $0.40, but the actual EPS was $0.39, resulting in a 20.0% price hike.

As of March 1, Nuvei’s shares were trading at $26.44, reflecting a 17.52% drop over the past year. With this downward trend, long-term investors may be anxious about the upcoming earnings announcement. To keep track of Nuvei’s earnings releases, investors can check their earnings calendar.

For more in-depth insights into Nuvei’s earnings outlook and performance, you can explore resources like Benzinga, TipRanks, and MarketBeat.

NVEI Stock Sees Slight Decline on March 4, 2024: Investors Monitor Price Momentum

On March 4, 2024, NVEI stock experienced a slight drop in its price performance. The stock opened at $26.69, which was $0.25 higher than its previous close. Throughout the trading day, the price of NVEI shares decreased by $0.48, resulting in a 1.82% drop from the market’s last close. Despite this decrease, NVEI is still trading in the middle of its 52-week range and above its 200-day simple moving average, indicating relative stability over the long term. Investors will be monitoring NVEI’s price momentum to see if the stock can reverse the downward trend seen on March 4. It will be important to observe how the stock performs in the coming days to determine if this drop is temporary or a more significant trend. Overall, NVEI’s stock performance on March 4, 2024, saw a slight decline, but the stock remains within a stable range compared to its historical performance. Investors will be watching closely to see how NVEI’s price movement evolves in the days ahead.

NVEI Stock Performance Analysis: Revenue Up, Net Income Down

On March 4, 2024, NVEI stock experienced mixed performances based on the financial data provided by CNN Money. The company’s total revenue for the past year was $843.32 million, showing a 16.4% increase compared to the previous year. However, in the third quarter, the total revenue dropped to $304.85 million, remaining flat compared to the previous quarter.

Net income for NVEI was $56.73 million for the past year, indicating a 44.54% decrease compared to the previous year. In the third quarter, the net income was reported as -$19.81 million, representing a significant decline of 299.68% compared to the previous quarter.

Earnings per share (EPS) for NVEI also showed a decline in performance. The EPS for the past year was $0.39, reflecting a 44.61% decrease compared to the previous year. In the third quarter, the EPS dropped to -$0.14, showing a substantial decrease of 299.16% compared to the previous quarter.

Tags: NVEI
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Biotechnology Stock Bull Market

Anticipation Builds for ChargePoint Holdings Quarterly Earnings Announcement

Redefining Success: How Franchises Adapt to Economic Shifts and Market Demands

Anticipation for FrancoNevadas Earnings Report A Look at Past Performance and Future Expectations

Real Estate Investment Trading online

Analyst Reiterates Neutral Rating on Green Brick Partners with Raised Price Target

Recommended

Gold Stock

Gold Nears Historic Peak as Market Anticipation Builds

2 months ago
Dentist

Advancements in Oral Healthcare: The Business Impact of Highly Trained Surgeons

2 years ago
Archer Aviation Stock

Archer Aviation Strengthens Market Position Through Strategic Patent Acquisition

4 months ago
SNDR stock news

Yousif Capital Management LLC Reduces Stake in Steven Madden, Ltd.: Implications for the Company’s Future Performance

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Trending

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

by Rodolfo Hanigan
February 7, 2026
0

Investor attention is turning to the upcoming catalysts for Design Therapeutics, a biotechnology firm advancing its GeneTAC...

Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Design Therapeutics Approaches Key Clinical Milestones with Ample Funding
  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com